Skip to search formSkip to main contentSkip to account menu

ONO 1301

Known as: ONO-1301 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The purpose of this study was to perform self-healing encapsulation of ONO-1301, a long-acting prostacyclin agonist, into poly… 
2013
2013
The purpose of this study was to evaluate the angiogenic potency of ONO-1301, a novel prostacyclin agonist, using a murine sponge… 
2012
2012
Tubulointerstitial injuries are crucial histological alterations that predict the deterioration of renal function in chronic… 
2012
2012
Objectives  ONO‐1301 was developed as a novel long‐acting prostacyclin agonist with thromboxane synthase inhibitory activity. In… 
2007
2007
It has been shown previously that administration of angiogenic growth factors as genes or proteins can augment collateral growth… 
Highly Cited
2006
Highly Cited
2006
The balance between prostacyclin and thromboxane A2 (TXA2) plays an important role in pulmonary homeostasis. However, little… 
1997
1997
The antinephritic effects of ONO-1301 ([7,8-dihydro-5-[(E)-[[a-(3-pyridyl)benzylidene]-aminooxy]ethyl]-1 -naphtyloxy]acetic acid…